On Tuesday, NanoRepro announced it acquired the remaining 67% of hyped about science GmbH, in which ...
Nanologica's Q2 did not live up to expectations and the market focused on the cash position, sending...
* Focus on the Power segment * Sales held up, earnings was weak * Divestment of Construction expecte...
Redeye returns with an update following Elicera's Q2 report and recent events in the company, includ...
KDventures' net asset value amounted to SEK677m at the end of the second quarter of 2026, driven by ...
Redeye briefly comments on Cinclus Pharma’s announcement that the last patient in the phase III HEEA...
Redeye returns with an update after Sprint Bioscience's Q2 report, which was in line with our expect...
XP Chemistries har tagit tydliga steg mot kommersialisering av sin inkapslade kapsaicinprodukt på dj...
Aiforia published its H1'26 report last Friday. Revenue of € 0.
Redeye provides its take on the performance of Aliens: Fireteam Elite 2 post launch, which has been ...
Kvartalet var i linje med våra estimat, med något högre hyresintäkter och driftnetto än väntat, meda...
Kvartalet var svagare än våra estimat, främst till följd av lägre nettoomsättning och en högre kostn...
Elon har startat 2026 med dunder och brak och följer den linje vi förutspått.
Efter AlzeCures avtal med Eli Lilly om ACD680 inväntar vi nya data från Roches ledande preparat för ...
Dellia ökade omsättningen med 5,4 % y-o-y till 167,1 MNOK i Q2'26.
Redeye states that INQ's (formerly Anoto) Q2 report was a clear net sales beat clouded by a sequenti...
InCoax has secured EUR80k in orders from Dutch VAR partner SmartMedia for two broadband projects, wi...
Eolus’ Q2 was largely as expected, with weak financials reflecting the absence of project transactio...
This Thursday, between 14:00-16:20, Redeye is hosting an Adtech Theme event.
NoHo is considering issuing EUR 50m of senior secured notes (4-year tenor) and replacing its current...